Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | RAD52 | P43351 | 1/20 | 0.39 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13423666 | 1.00 | EPHX1 (0.80) | EPHX1ALDH1A1CYP1A2TDP1TP53 | |
| SCHEMBL409221 | 1.00 | EPHX1 (0.80) | EPHX1ALDH1A1CYP1A2TDP1TP53 | |
| SCHEMBL5515259 | 1.00 | EPHX1 (0.80) | EPHX1ALDH1A1CYP1A2TDP1TP53 | |
| SCHEMBL4626384 | 1.00 | EPHX1 (0.80) | EPHX1ALDH1A1CYP1A2TDP1TP53 | |
| SCHEMBL18825665 | 1.00 | EPHX1 (0.80) | EPHX1ALDH1A1CYP1A2TDP1TP53 | |
| SCHEMBL20440346 | 1.00 | EPHX1 (0.80) | EPHX1ALDH1A1CYP1A2TDP1TP53 | |
| SCHEMBL1602429 | 0.98 | EPHX1 (0.76) | EPHX1ALDH1A1CYP1A2TDP1TP53 | |
| 2-(Hexadecyl)Tetrahydrofuran SCHEMBL3663252 | 0.96 | EPHX1 (0.74) | EPHX1ALDH1A1CYP1A2TDP1TP53 | |
| Methoxymethane SCHEMBL28364135 | 0.94 | EPHX1 (0.71) | EPHX1ALDH1A1CYP1A2TDP1TP53 | |
| SCHEMBL28376605 | 0.94 | EPHX1 (0.71) | EPHX1ALDH1A1CYP1A2TDP1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139195-A1 | Sustainable 2-Alkyltetrahydrofuran Fuels for Compression Ignition Engines | THE US SECRETARY OF THE NAVY (US) | 2026-05-21 | — | — | US | claimed |
| EP-4096618-B1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2025-01-29 | — | — | EP | claimed |
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| US-20240050337-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2024-02-15 | — | — | US | claimed |
| CN-116490160-A | A mixture containing 1, 2-alkanediol | 西姆莱斯股份公司 | 2023-07-25 | — | — | CN | claimed |
| EP-4096618-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2022-12-07 | — | — | EP | claimed |
| US-20220364016-A1 | PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2022-11-17 | — | — | US | claimed |
| WO-2022122143-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | claimed |
| US-20220023268-A1 | CRYSTALLINE FORMS OF 3-[5-(2-FLUOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZOIC ACID FOR THE TREATMENT OF DISEASE | PTC THERAPEUTICS, INC. | 2022-01-27 | — | — | US | claimed |
| WO-2006095200-A1 | PERFUME COMPOSITIONS | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2006-09-14 | — | — | WO | claimed |
| EP-0915898-B1 | CRYSTAL FORM I OF CLARITHROMYCIN | ABBOTT LAB (US) | 2003-12-03 | — | — | EP | claimed |
| EP-0915898-A1 | CRYSTAL FORM I OF CLARITHROMYCIN | Abbott Laboratories (US) | 1999-05-19 | — | — | EP | claimed |
| US-5858986-A | CONVERTING ERYTHROMYCIN A INTO ITS 9-OXIME DERIVATIVE; PROTECTING 2' AND 4? HYDROXY GROUPS; METHYLATION; DEPROTECTING AND DEOXIMATING; TREATING WITH SOLVENT; ISOLATION; DRYING | ABBOTT LABORATORIES (US) | 1999-01-12 | — | — | US | claimed |
| WO-1998004573-A1 | CRYSTAL FORM I OF CLARITHROMYCIN | ABBOTT LABORATORIES (US) | 1998-02-05 | — | — | WO | claimed |
| WO-1993021296-A1 | AQUEOUS LIQUID BLEACH COMPOSITIONS WITH FLUORESCENT WHITENING AGENT AND POLYVINYL PYRROLIDONE OR POLYVINYL ALCOHOL | THE PROCTER & GAMBLE COMPANY (US) | 1993-10-28 | — | — | WO | claimed |
| WO-1993021295-A1 | LIQUID OR GEL BLEACHING COMPOSITION CONTAINING AMIDOPEROXYACID BLEACH AND PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1993-10-28 | — | — | WO | claimed |
| US-5248434-A | Stability | THE PROCTOR & GAMBLE COMPANY (US) | 1993-09-28 | — | — | US | claimed |
| US-5234617-A | Cleaning, bleaching fabrics | Hunter, Kathleen B. (US) | 1993-08-10 | — | — | US | claimed |
| US-3993581-A | WITH A PHOSPHOLIPID AS EMULSIFIER AND A FATTY ACID, ALKALI METAL SALT OR ITS MONOGLYCERIDE AS AN ADJUVANT | THE GREEN CROSS CORPORATION (JA) | 1976-11-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220023268-A1 | CRYSTALLINE FORMS OF 3-[5-(2-FLUOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZOIC ACID FOR THE TREATMENT OF DISEASE | UPF1, RNMT, RBM17 | EPHX1 4682/4885ALDH1A1 3498/4885CYP1A2 3914/4885 |
| US-20240050337-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | OR10J3, OR51E2, MAL2 | EPHX1 1836/4885ALDH1A1 27/4885CYP1A2 90/4885 |
| US-20260139195-A1 | Sustainable 2-Alkyltetrahydrofuran Fuels for Compression Ignition Engines | FFAR2, FFAR1, FFAR4 | EPHX1 2631/4885ALDH1A1 617/4885CYP1A2 2161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.